Clinical Trial Update: Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets of Enalapril [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports follow-up safety data for enalapril given as orodispersible minitablets in children with chronic heart failure (Phase 2/Phase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Dilated Cardiomyopathy
• Heart Failure

Drugs mentioned

• Enalapril (enalapril)

Snippet

Sponsor: Ethicare GmbH | Conditions: Heart Failure, Dilated Cardiomyopathy | Phase 2, Phase 3 | Status: UNKNOWN